Hypopigmentation: Clinical Trials

7 trials for Hypopigmentation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Unknown 7

Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo
Methotrexate, 5-fluorouracil, Fractional CO2 laser - Vitiligo
Phase 4UnknownAssiut University502022-09-012022-05-09
Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo
Topical travoprost 0.004% solution, Fractional CO2 laser, Excimer laser - Vitiligo, Excimer Laser
Phase 4UnknownAssiut University302021-01-012020-10-22
Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo
NB-UVB, NB-UVB & Tacrolimus 0.03% - Vitiligo
Phase 4UnknownSouth Valley University1002017-09-012018-09-06
Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients
ReCell epidermal cell suspension grafting, CO2 laser abrasion + UV-therapy - Piebaldism, Segmental Vitiligo
Phase 4UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)102012-06-012013-08-05
Punchgrafting Techniques for Vitiligo
punchgrafting - Non-segmental Vitiligo, Segmental Vitiligo
Phase 4UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)352011-06-012011-06-21
Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
Fluticasone proprionate 0.05% cream - Patients With Active Non-segmental Vitiligo., Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%
Phase 4UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)502009-09-012010-11-24
Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
tacrolimus ointment, Mometasone furoate - Vitiligo
Phase 4UnknownMahidol University302009-06-012012-10-10

Narrower conditions

Vitiligo (6)  ·  Piebaldism (2)  ·  Personal Satisfaction (1)

Broader conditions

Pigmentation Disorders (7)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Albinism (2)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Eye Diseases, Hereditary (2)  ·  Genetic Diseases, Inborn (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Behavior (1)

Interventions

Combined Modality Therapy (1)  ·  Fluorouracil (1)  ·  Lasers, Excimer (1)  ·  Methotrexate (1)  ·  Mometasone Furoate (1)  ·  Solutions (1)  ·  Tacrolimus (1)  ·  Travoprost (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3)  ·  Assiut University (2)  ·  Mahidol University (1)  ·  South Valley University (1)

Countries

Netherlands (3)  ·  Egypt (1)  ·  Thailand (1)

Top investigators

Chanisada Wongpraparut, M.D. (1)  ·  Ramdan Saleh, MD (1)

Results publications

PMID 42319271